These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 26752662)

  • 1. Antimicrobial Stewardship in a Long-Term Acute Care Hospital Using Offsite Electronic Medical Record Audit.
    Beaulac K; Corcione S; Epstein L; Davidson LE; Doron S
    Infect Control Hosp Epidemiol; 2016 Apr; 37(4):433-9. PubMed ID: 26752662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lessons learned from implementing Clostridium difficile-focused antibiotic stewardship interventions.
    Ostrowsky B; Ruiz R; Brown S; Chung P; Koppelman E; van Deusen Lukas C; Guo Y; Jalon H; Sumer Z; Araujo C; Sirtalan I; Brown C; Riska P; Currie B
    Infect Control Hosp Epidemiol; 2014 Oct; 35 Suppl 3():S86-95. PubMed ID: 25222903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two time-series analyses of the impact of antibiotic consumption and alcohol-based hand disinfection on the incidences of nosocomial methicillin-resistant Staphylococcus aureus infection and Clostridium difficile infection.
    Kaier K; Hagist C; Frank U; Conrad A; Meyer E
    Infect Control Hosp Epidemiol; 2009 Apr; 30(4):346-53. PubMed ID: 19236282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sustained reduction in antimicrobial use and decrease in methicillin-resistant Staphylococcus aureus and Clostridium difficile infections following implementation of an electronic medical record at a tertiary-care teaching hospital.
    Cook PP; Rizzo S; Gooch M; Jordan M; Fang X; Hudson S
    J Antimicrob Chemother; 2011 Jan; 66(1):205-9. PubMed ID: 21059617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of colonization and infection with methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus and of Clostridium difficile infection in Canadian hospitals.
    Simor AE; Williams V; McGeer A; Raboud J; Larios O; Weiss K; Hirji Z; Laing F; Moore C; Gravel D;
    Infect Control Hosp Epidemiol; 2013 Jul; 34(7):687-93. PubMed ID: 23739072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of national antibiotic stewardship and infection control strategies on hospital-associated and community-associated meticillin-resistant Staphylococcus aureus infections across a region of Scotland: a non-linear time-series study.
    Lawes T; Lopez-Lozano JM; Nebot CA; Macartney G; Subbarao-Sharma R; Dare CR; Wares KD; Gould IM
    Lancet Infect Dis; 2015 Dec; 15(12):1438-49. PubMed ID: 26411518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of an antimicrobial stewardship programme on antimicrobial utilisation and costs in patients with leukaemia: a retrospective controlled study.
    So M; Mamdani MM; Morris AM; Lau TTY; Broady R; Deotare U; Grant J; Kim D; Schimmer AD; Schuh AC; Shajari S; Steinberg M; Bell CM; Husain S
    Clin Microbiol Infect; 2018 Aug; 24(8):882-888. PubMed ID: 29138099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term outcomes of an antimicrobial stewardship program implemented in a hospital with low baseline antibiotic use.
    Jenkins TC; Knepper BC; Shihadeh K; Haas MK; Sabel AL; Steele AW; Wilson ML; Price CS; Burman WJ; Mehler PS
    Infect Control Hosp Epidemiol; 2015 Jun; 36(6):664-72. PubMed ID: 25740560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Secular trends in the epidemiology of Clostridium difficile infection (CDI): relationship with alcohol gel and antimicrobial usage in a hospital.
    Silva M; Marra AR; Camargo TZ; Almeida SM; Siqueira I; Correa L; Kawagoe JY; dos Santos OF; Edmond MB
    Int J Infect Dis; 2013 Jun; 17(6):e418-21. PubMed ID: 23419978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of guidelines and enhanced antibiotic stewardship on reducing broad-spectrum antibiotic usage and its effect on incidence of Clostridium difficile infection.
    Talpaert MJ; Gopal Rao G; Cooper BS; Wade P
    J Antimicrob Chemother; 2011 Sep; 66(9):2168-74. PubMed ID: 21676904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multipronged intervention strategy to control an outbreak of Clostridium difficile infection (CDI) and its impact on the rates of CDI from 2002 to 2007.
    Weiss K; Boisvert A; Chagnon M; Duchesne C; Habash S; Lepage Y; Letourneau J; Raty J; Savoie M
    Infect Control Hosp Epidemiol; 2009 Feb; 30(2):156-62. PubMed ID: 19125681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of continued antibacterial therapy after diagnosis of hospital-onset Clostridium difficile infection: implications for antimicrobial stewardship.
    Harpe SE; Inocencio TJ; Pakyz AL; Oinonen MJ; Polk RE
    Pharmacotherapy; 2012 Aug; 32(8):744-54. PubMed ID: 23307522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction in broad-spectrum antimicrobial use associated with no improvement in hospital antibiogram.
    Cook PP; Catrou PG; Christie JD; Young PD; Polk RE
    J Antimicrob Chemother; 2004 May; 53(5):853-9. PubMed ID: 15044426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduction of fluoroquinolone use is associated with a decrease in methicillin-resistant Staphylococcus aureus and fluoroquinolone-resistant Pseudomonas aeruginosa isolation rates: a 10 year study.
    Lafaurie M; Porcher R; Donay JL; Touratier S; Molina JM
    J Antimicrob Chemother; 2012 Apr; 67(4):1010-5. PubMed ID: 22240401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence of Clostridium difficile infections in patients receiving antimicrobial and acid-suppression therapy.
    King RN; Lager SL
    Pharmacotherapy; 2011 Jul; 31(7):642-8. PubMed ID: 21923450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of fluoroquinolone restriction (from 2007 to 2012) on Clostridium difficile infections: interrupted time-series analysis.
    Sarma JB; Marshall B; Cleeve V; Tate D; Oswald T; Woolfrey S
    J Hosp Infect; 2015 Sep; 91(1):74-80. PubMed ID: 26169793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation to identify a resource-efficient case-control methodology for determining antibiotics associated with Clostridium difficile infection.
    Chung P; Currie B; Guo Y; Talansky M; Brown S; Ostrowsky B
    Am J Infect Control; 2014 Oct; 42(10 Suppl):S264-8. PubMed ID: 25239720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of real-time notification of Clostridium difficile test results and early initiation of effective antimicrobial therapy.
    Polen CB; Judd WR; Ratliff PD; King GS
    Am J Infect Control; 2018 May; 46(5):538-541. PubMed ID: 29305281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Approaching zero: temporal effects of a restrictive antibiotic policy on hospital-acquired Clostridium difficile, extended-spectrum β-lactamase-producing coliforms and meticillin-resistant Staphylococcus aureus.
    Dancer SJ; Kirkpatrick P; Corcoran DS; Christison F; Farmer D; Robertson C
    Int J Antimicrob Agents; 2013 Feb; 41(2):137-42. PubMed ID: 23276500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An evaluation of the impact of antibiotic stewardship on reducing the use of high-risk antibiotics and its effect on the incidence of Clostridium difficile infection in hospital settings.
    Aldeyab MA; Kearney MP; Scott MG; Aldiab MA; Alahmadi YM; Darwish Elhajji FW; Magee FA; McElnay JC
    J Antimicrob Chemother; 2012 Dec; 67(12):2988-96. PubMed ID: 22899806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.